This is a news story, published by New Atlas, that relates primarily to Oregon Health and Science University news.
For more disease research news, you can click here:
more disease research newsFor more news from New Atlas, you can click here:
more news from New AtlasOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like disease research news, you might also like this article about
pancreatic cancer. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest pancreatic ductal adenocarcinoma news, pancreatic disease news, disease research news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
current best clinical biomarkerNew Atlas
•Health
Health
84% Informative
Scientists at Oregon Health and Science University have developed a new blood test for pancreatic cancer.
Tests showed up to 85% accuracy in detection, even in early stages.
PAC-MANN was able to identify 73% of pancreatic ductal adenocarcinoma cases across all stages.
It was also able to rule out 98% of patients without cancer.
VR Score
88
Informative language
92
Neutral language
12
Article tone
informal
Language
English
Language complexity
51
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
long-living
External references
3
Source diversity
3
Affiliate links
no affiliate links
